Login to Your Account



Pharma: Clinic Roundup


Tuesday, March 5, 2013
• Teva Pharmaceutical Industries Ltd., of Jerusalem, said results of a Phase III trial of Milprosa (progesterone) vaginal ring were published in Fertility and Sterility.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription